VRNA Live signals | Maximize Profits with Getagraph.com

BUY 94086 min ago

@ $17.52

Issued: 14 Feb 2024 @ 15:40

Return: -10.27%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: 1.15 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs...

Stats
Today's Volume	633 858
Average Volume	446 352
Market Cap	1.26B
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.240 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-21.83
ATR14	$0.0290 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Fisher Andrew	Buy	2 400 000	Share Options (Right to Buy)
2024-03-04	Fisher Andrew	Buy	0
2024-02-01	Zaccardelli David	Sell	480 200	Ordinary Shares
2024-02-01	Rickard Kathleen A.	Sell	72 768	Ordinary Shares
2024-02-05	Rickard Kathleen A.	Sell	36 248	Ordinary Shares

INSIDER POWER
-13.65
Last 97 transactions
Buy: 7 137 944 \| Sell: 12 997 482

Volume Correlation

Long: 0.00 (neutral)

Short: 0.21 (neutral)

Signal:(63.258) Neutral

Verona Pharma plc Correlation

10 Most Positive Correlations
SIOX	0.953
BWEN	0.952
ECHO	0.952
MLVF	0.951
IIN	0.95
AMYT	0.947
EXAS	0.943
NWLI	0.939
CDZI	0.936
EEFT	0.93

10 Most Negative Correlations
PCRX	-0.936
SNPX	-0.935
KPTI	-0.93
HMNF	-0.93
LARK	-0.927
UTME	-0.926
SGLB	-0.918
OP	-0.909
BCAB	-0.909
VNDA	-0.909

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Verona Pharma plc Correlation - Currency/Commodity

0.06
( neutral )

0.24
( neutral )

0.00
( neutral )

0.11
( neutral )

0.50
( neutral )

-0.16
( neutral )

Verona Pharma plc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-679 624 (0.00 %)
EPS:	$-0.690

Q4	2023
Revenue:	$0
Gross Profit:	$-209 809 (0.00 %)
EPS:	$-0.180

Q3	2023
Revenue:	$0
Gross Profit:	$-154 100 (0.00 %)
EPS:	$-0.180

Q2	2023
Revenue:	$0
Gross Profit:	$-157 504 (0.00 %)
EPS:	$-0.110

Financial Reports:

No articles found.

Verona Pharma plc

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.